We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCOM
2126
DELISTED
Points.com Inc. Common Shares
PCOM
$1.12M ﹤0.01%
90,933
+3,192
+4% +$38.9K
CBLK
2127
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$1.12M ﹤0.01%
66,794
+17,448
+35% +$268K
CTSO icon
2128
Cytosorbents Corp
CTSO
$22.8M
$1.12M ﹤0.01%
168,800
FFWM
2129
DELISTED
First Foundation Inc
FFWM
$1.11M ﹤0.01%
82,893
-5,650
-6% -$77.9K
CYH icon
2130
Community Health Systems
CYH
$413M
$1.11M ﹤0.01%
+417,017
New +$1.32M
BIT icon
2131
BlackRock Multi-Sector Income Trust
BIT
$704M
$1.11M ﹤0.01%
63,483
+4,438
+8% +$75.1K
GIII icon
2132
G-III Apparel Group
GIII
$1.46B
$1.11M ﹤0.01%
37,670
-16,087
-30% -$549K
LDP icon
2133
Cohen & Steers Duration Preferred & Income Fund
LDP
$601M
$1.11M ﹤0.01%
44,521
+3,359
+8% +$81.4K
ICVT icon
2134
iShares Convertible Bond ETF
ICVT
$7.44B
$1.1M ﹤0.01%
18,548
-3,529
-16% -$207K
DCF
2135
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$1.1M ﹤0.01%
118,020
+10,589
+10% +$95.7K
CCOI icon
2136
Cogent Communications
CCOI
$514M
$1.1M ﹤0.01%
+18,516
New +$1.06M
SNCR
2137
DELISTED
Synchronoss Technologies
SNCR
$1.1M ﹤0.01%
15,442
-9,132
-37% -$515K
RFUN
2138
DELISTED
RiverFront Dynamic Unconstrained Income
RFUN
$1.1M ﹤0.01%
43,461
+3,910
+10% +$98.4K
PGJ icon
2139
Invesco Golden Dragon China ETF
PGJ
$98M
$1.1M ﹤0.01%
29,296
-243
-0.8% -$9.37K
ITCI
2140
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.1M ﹤0.01%
84,450
+15,800
+23% +$203K
TVTY
2141
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$1.09M ﹤0.01%
+66,503
New +$1.28M
DURA icon
2142
VanEck Durable High Dividend ETF
DURA
$39M
$1.09M ﹤0.01%
+38,873
New +$1.07M
DUSA icon
2143
Davis Select US Equity ETF
DUSA
$1.28B
$1.08M ﹤0.01%
46,317
+3,162
+7% +$73.5K
PSEC icon
2144
Prospect Capital
PSEC
$1.15B
$1.08M ﹤0.01%
165,988
+41,785
+34% +$277K
GNL icon
2145
Global Net Lease
GNL
$1.95B
$1.08M ﹤0.01%
55,189
+10,670
+24% +$203K
IBDQ
2146
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$1.08M ﹤0.01%
42,057
+3,822
+10% +$95.6K
W icon
2147
Wayfair
W
$14.2B
$1.07M ﹤0.01%
7,326
+2,568
+54% +$386K
NBEV
2148
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$1.07M ﹤0.01%
228,846
+58,466
+34% +$299K
CSM icon
2149
ProShares Large Cap Core Plus
CSM
$534M
$1.06M ﹤0.01%
30,212
+1,950
+7% +$67.9K
DCUD
2150
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
$1.06M ﹤0.01%
21,166
+507
+2% +$25.2K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.